Medical Experts Advocate for PMOS Terminology to Better Reflect Complex Metabolic Disorder
Medical specialists are increasingly supporting a terminology change from PCOS to PMOS, contending that the revised naming convention more accurately reflects the true nature of the condition affecting millions of women globally.
The fundamental issue with the traditional term, according to Dr Varini N, Senior Consultant in Obstetrics and Gynaecology at Milann Fertility and Birthing Hospital, lies in a widespread misconception. "The term PCOS is mostly focused on ovarian conditions. It is a misnomer as there are no ovarian cysts. The polycystic appearance are actually multiple follicles produced by ovaries in response to hormonal imbalance."
The nomenclature shift to Polyendocrine Metabolic Ovarian Syndrome encompasses far broader implications. This new designation acknowledges that the condition disrupts multiple physiological systems—hormones, metabolism, skin health, mental wellbeing, fertility, and cardiovascular function—rather than being primarily a reproductive concern.
The Diagnostic Problem
The emphasis on "polycystic" has created significant clinical challenges. Women presenting with normal ovarian ultrasounds but experiencing irregular menstruation, acne, weight fluctuations, or hair loss have historically been dismissed as not having the condition. Research indicates that up to 50 percent of individuals with this syndrome lack the characteristic ovarian features visible on imaging.
This narrow diagnostic lens has led to fragmented healthcare approaches. Patients receive treatment for acne or menstrual irregularities while underlying insulin resistance, elevated cardiovascular risk, fatty liver disease, and mental health complications go unaddressed.
A 22-year-old woman's experience illustrates this problem. Presenting with excessive facial hair, acne, significant weight gain, and highly irregular cycles, she initially consulted a dermatologist. Her ultrasound revealed normal ovaries, leading the specialist to conclude she lacked the condition. She received topical treatments for facial hair and acne while her irregular cycles and weight issues were overlooked for two to three years. Only when she later consulted a gynaecologist was she informed that despite normal ultrasound findings, her clinical presentation indicated the syndrome, resulting in delayed intervention.
A Comprehensive Diagnostic Approach
Modern evaluation now prioritizes an integrated assessment of hormonal and metabolic parameters rather than relying solely on imaging. Specialists examine irregular menstrual patterns, indicators of androgen excess such as acne or hirsutism, unexplained weight gain, insulin resistance, and metabolic abnormalities. Psychological manifestations including anxiety, body image concerns, and mood disturbances receive increased consideration.
Comprehensive diagnostic workup typically includes hormone assessments—testosterone, luteinizing hormone, follicle-stimulating hormone, thyroid profile, and prolactin levels—alongside insulin evaluation. Blood glucose levels, HbA1c measurements, lipid panels, and ovarian ultrasound are commonly ordered. Significantly, ultrasound findings alone no longer constitute mandatory diagnostic criteria for every patient.
This multifaceted approach facilitates earlier identification and enables treatment strategies addressing not merely reproductive concerns but also long-term metabolic and cardiovascular wellbeing.
Prevalence Among Urban Indian Women
The condition increasingly affects urban Indian populations, where sedentary routines, psychological stress, disrupted sleep patterns, and dietary shifts serve as contributing factors. Indian research estimates approximately one in five women in metropolitan areas may demonstrate PMOS-associated features, though numerous cases remain undiagnosed.
The syndrome typically emerges during adolescence and early adulthood, with peak identification occurring between ages 15 and 35. A troubling pattern exists: many women disregard symptoms including irregular periods, acne, or weight changes and postpone medical consultation until fertility complications arise.
Recognizing Symptoms
Women should not dismiss persistent menstrual irregularities—cycles that are consistently delayed, absent, or unpredictable. Additional warning signs include treatment-resistant acne, excessive facial or body hair development, scalp hair thinning, and unexplained weight gain despite lifestyle adjustments.
Other manifestations encompass fatigue, mood fluctuations, skin darkening around the neck or underarms stemming from insulin resistance, and sleep disruptions. Some women experience infertility or conception difficulties later in life.
Critically, symptom presentation varies considerably among individuals. Not every woman with this syndrome displays visible ovarian cysts or obesity. Lean women can develop the condition through hormonal and metabolic dysfunction alone.
Long-Term Health Implications
Untreated disease significantly elevates risks for type 2 diabetes, cardiovascular disease, and endometrial complications alongside reproductive concerns, underscoring the importance of timely medical evaluation.
Adolescent identification is particularly valuable. Within several years following menstruation onset, persistent irregular cycles, severe acne, excessive hair growth, or rapid weight gain warrant careful evaluation, though clinicians must distinguish between pathological hormonal disruption and normal pubertal fluctuations.
Early diagnosis prevents long-term complications. Prompt lifestyle modifications, nutritional support, weight management, and hormonal or metabolic interventions can normalize menstrual cycles, enhance insulin sensitivity, minimize future fertility problems, and reduce diabetes and cardiovascular disease risk.
The psychological dimension demands equal attention. Many young women experience silent struggles with body image concerns, anxiety, or diminished self-worth connected to syndrome symptoms. Timely counselling and comprehensive support substantially enhance quality of life.
The terminology transition from PCOS to PMOS fundamentally reframes understanding: this represents not merely a fertility condition but rather a lifelong metabolic and endocrine disorder benefiting substantially from early, coordinated multidisciplinary management.
Compare options


